Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients

被引:19
作者
Fuster, D. [1 ,2 ]
Sanvisens, A. [1 ]
Bolao, F. [3 ]
Serra, I. [4 ]
Rivas, I. [5 ]
Tor, J. [1 ]
Muga, R. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Germans Trias & Pujol, Dept Internal Med, E-08193 Barcelona, Spain
[2] Boston Univ, Sch Med, Boston Med Ctr, Gen Internal Med Sect, Boston, MA 02118 USA
[3] Univ Barcelona, Hosp Univ Bellvitge, Dept Internal Med, E-08007 Barcelona, Spain
[4] Univ Autonoma Barcelona, Fundacio Inst Invest Germans Trias & Pujol, Hosp Univ Germans Trias & Pujol, Dept Gastroenterol,Liver Unit, E-08193 Barcelona, Spain
[5] IMSP, Municipal Ctr Substance Abuse Treatment, Ctr Delta, Badalona, Spain
关键词
alcohol dependence; HCV infection; liver-related mortality; survival; LIVER FIBROSIS PROGRESSION; INJECTION-DRUG USERS; NATURAL-HISTORY; USE DISORDERS; HIV; MORTALITY; CIRRHOSIS; POPULATION; DISEASE; METAANALYSIS;
D O I
10.1111/jvh.12290
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) infection is frequent among patients with alcohol use disorders. We aimed to analyse the impact of HCV infection on survival of patients seeking treatment for alcohol use. This was a longitudinal study in a cohort of patients who abused alcohol recruited in two detoxification units. Socio-demographic and alcohol use characteristics, liver function tests for the assessment of alcohol-related liver disease and HCV and HIV infection serologies were obtained at admission. Patients were followed until December 2008; causes of death were ascertained through clinical records and death registry. Cox models were used to analyse predictors of death. A total of 675 patients (79.7% men) were admitted; age at admission was 43.5years (IQR: 37.9-50.2years), duration of alcohol abuse was 18years (IQR: 11-24years), and median alcohol consumption was 200g/day (IQR: 120-275g/day). Distribution of patients according to viral infections was as follows: 75.7% without HCV or HIV infection, 14.7% HCV infection alone and 8.1% HCV/HIV coinfection. Median follow-up was 3.1years (IQR: 1.5-5.1years) accounting for 2,345 person-years. At the end of study, 78 patients (11.4%) had died. In the multivariate analysis, age at admission (HR=1.71, 95%CI: 1.05-2.80), alcohol-related liver disease (HR=3.55, 95%CI: 1.93-6.53) and HCV/HIV co-infection (HR=3.86 95%CI: 2.10-7.11) were predictors of death. Younger patients (43years) with HCV infection were more likely to die than those without viral infections (HR=3.1, 95%CI: 1.3-7.3; P=0.007). Among patients with alcohol-related liver disease, mortality rate was high, irrespective of viral infections. These data show that HCV infection confers a worse prognosis in patients with alcohol use disorders.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 38 条
  • [21] Unhealthy Alcohol Use, HIV Infection and Risk of Liver Fibrosis in Drug Users with Hepatitis C
    Muga, Roberto
    Sanvisens, Arantza
    Fuster, Daniel
    Tor, Jordi
    Martinez, Elisenda
    Perez-Hoyos, Santiago
    Munoz, Alvaro
    [J]. PLOS ONE, 2012, 7 (10):
  • [22] Alcoholic Liver Disease
    O'Shea, Robert S.
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    [J]. HEPATOLOGY, 2010, 51 (01) : 307 - 328
  • [23] Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study
    Obel, Niels
    Omland, Lars Haukali
    Kronborg, Gitte
    Larsen, Carsten S.
    Pedersen, Court
    Pedersen, Gitte
    Sorensen, Henrik Toft
    Gerstoft, Jan
    [J]. PLOS ONE, 2011, 6 (07):
  • [24] Mortality among Patients with Cleared Hepatitis C Virus Infection Compared to the General Population: A Danish Nationwide Cohort Study
    Omland, Lars Haukali
    Christensen, Peer Brehm
    Krarup, Henrik
    Jepsen, Peter
    Weis, Nina
    Sorensen, Henrik Toft
    Obel, Niels
    [J]. PLOS ONE, 2011, 6 (07):
  • [25] Piasecki BA, 2004, HEPATOLOGY, V40, P892, DOI 10.1002/hep.1840400419
  • [26] HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis
    Pineda, JA
    Romero-Gómez, M
    Díaz-García, F
    Girón-González, JA
    Montero, JL
    Torre-Cisneros, J
    Andrade, TJ
    González-Serrano, M
    Aguilar, J
    Aguilar-Guisado, M
    Navarro, JM
    Salmerón, J
    Caballero-Granado, FJ
    García-García, JA
    [J]. HEPATOLOGY, 2005, 41 (04) : 779 - 789
  • [27] Natural history of liver fibrosis progression in patients with chronic hepatitis C
    Poynard, T
    Bedossa, P
    Opolon, P
    [J]. LANCET, 1997, 349 (9055) : 825 - 832
  • [28] Impact of Medical Comorbidity and Risk of Death in 680 Patients with Alcohol Use Disorders
    Rivas, Inmaculada
    Sanvisens, Arantza
    Bolao, Ferran
    Fuster, Daniel
    Tor, Jordi
    Pujol, Ramon
    Torrens, Marta
    Rey-Joly, Celestino
    Muga, Robert
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 : E221 - E227
  • [29] Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)
    Rosenthal, E
    Poirée, M
    Pradier, C
    Perronne, C
    Salmon-Ceron, D
    Geffray, L
    Myers, RP
    Morlat, P
    Pialoux, G
    Pol, S
    Cacoub, P
    [J]. AIDS, 2003, 17 (12) : 1803 - 1809
  • [30] Rosman AS, 1996, AM J GASTROENTEROL, V91, P498